Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | No | Yes |
Is net profit margin increasing? | No | Yes |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Evonik Industries AG |
LANXESS Aktiengesellschaft |
Syensqo SA/NV |
Novozymes A/S |
Covestro AG |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
EVK | LXS | 2NF | NZM2 | 1CO | BAS | |||
Return On Equity | ||||||||
Latest Twelve Months | 3% | -3% | -1% | 7% | -6% | 2% | ||
Fiscal Year - 1 | -5% | -19% | 3% | 22% | -3% | 1% | ||
Fiscal Year - 2 | 5% | 5% | 21% | 29% | -4% | -2% | ||
Fiscal Year - 3 | 9% | 3% | 12% | 27% | 24% | 15% | ||
Fiscal Year - 4 | 6% | 31% | -42% | 25% | 8% | -4% | ||
Fiscal Year - 5 | 9% | 9% | NA | 28% | 10% | 6% | ||
Average | 5% | 4% | -2% | 23% | 5% | 3% | ||
Median | 6% | 4% | 3% | 26% | 3% | 1% | ||
Benchmarks | Ticker | |||||||
Evonik Industries AG | XTRA:EVK | |||||||
LANXESS Aktiengesellschaft | XTRA:LXS | |||||||
Syensqo SA/NV | DUSE:2NF | |||||||
Novozymes A/S | DB:NZM2 | |||||||
Covestro AG | XTRA:1CO |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | EVK | LXS | 2NF | NZM2 | 1CO | BAS | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | ||
Revenues | ||||||||
Latest Twelve Months | 15,138 | 6,360 | 6,803 | 4,058 | 14,146 | 65,109 | ||
Fiscal Year | 15,157 | 6,366 | 6,846 | 3,834 | 14,179 | 65,260 | ||
Fiscal Year - 1 | 15,267 | 6,714 | 7,065 | 2,402 | 14,377 | 68,902 | ||
Fiscal Year - 2 | 18,488 | 8,088 | 8,123 | 2,360 | 17,968 | 87,327 | ||
Fiscal Year - 3 | 14,955 | 6,101 | 6,032 | 2,009 | 15,903 | 78,598 | ||
Fiscal Year - 4 | 12,199 | 6,104 | 5,381 | 1,883 | 10,706 | 59,149 | ||
Fiscal Year - 5 | 13,108 | 6,802 | NA | 1,924 | 12,412 | 59,316 | ||
Net Income | ||||||||
Latest Twelve Months | 299 | (136) | (108) | 459 | (391) | 738 | ||
Fiscal Year | 222 | (177) | (5) | 306 | (266) | 1,298 | ||
Fiscal Year - 1 | (465) | (843) | 193 | 406 | (198) | 225 | ||
Fiscal Year - 2 | 539 | 184 | 950 | 494 | (272) | (627) | ||
Fiscal Year - 3 | 748 | 116 | 444 | 423 | 1,616 | 5,559 | ||
Fiscal Year - 4 | 489 | 892 | (1,285) | 380 | 459 | (1,456) | ||
Fiscal Year - 5 | 753 | 255 | NA | 422 | 552 | 2,476 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 20,448 | 9,711 | 13,228 | NA | 13,729 | 81,740 | ||
Latest Fiscal Quarter | 20,242 | 9,512 | 12,138 | 15,057 | 14,053 | 81,419 | ||
Fiscal Year | 19,750 | 9,711 | 12,373 | 15,196 | 13,631 | 80,415 | ||
Fiscal Year - 1 | 19,940 | 9,665 | 12,894 | 3,809 | 13,637 | 77,395 | ||
Fiscal Year - 2 | 21,810 | 11,287 | 13,633 | 3,762 | 14,585 | 84,472 | ||
Fiscal Year - 3 | 22,284 | 10,528 | 12,675 | 3,329 | 15,571 | 87,383 | ||
Fiscal Year - 4 | 20,897 | 8,880 | 11,371 | 2,756 | 12,924 | 80,292 | ||
Fiscal Year - 5 | 22,023 | 8,695 | NA | 2,735 | 11,518 | 86,950 | ||
Fiscal Year - 6 | 20,282 | 8,687 | NA | 2,638 | 11,084 | 86,556 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 9,138 | 4,555 | 7,739 | 1,876 | 6,619 | 37,167 | ||
Latest Fiscal Quarter | 9,185 | 4,358 | 7,215 | 11,231 | 6,408 | 36,085 | ||
Fiscal Year | 9,020 | 4,586 | 7,433 | 11,176 | 6,658 | 35,599 | ||
Fiscal Year - 1 | 8,910 | 4,501 | 7,567 | 1,876 | 6,590 | 35,277 | ||
Fiscal Year - 2 | 10,974 | 4,421 | 4,922 | 1,860 | 7,086 | 39,573 | ||
Fiscal Year - 3 | 9,289 | 3,756 | 4,315 | 1,590 | 7,696 | 40,792 | ||
Fiscal Year - 4 | 8,012 | 3,001 | 3,065 | 1,509 | 5,607 | 33,728 | ||
Fiscal Year - 5 | 8,970 | 2,669 | NA | 1,535 | 5,207 | 41,497 | ||
Fiscal Year - 6 | 7,729 | 2,780 | NA | 1,530 | 5,342 | 35,054 |